VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
BBOTBridgeBio Oncology Therapeutics Inc.
$7.87$630M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksBBOTPrice History

BBOT logoBridgeBio Oncology Therapeutics Inc. (BBOT) Stock Price History

Historical prices from 2024 to 2026

$7.87+0.31  (+4.10%)close Jun 22
Returns
1M
-13.6%
3M
-14.9%
YTD
-38.5%
1Y
-30.4%
3Y
-9.5%
5Y
-5.8%
ATH$14.87Dec 2025-47.1%
ATL$7.01Jun 2026pre-split
Avg Vol (50D)408K/ day
52-Week Range$7.01 — $14.87
LowCurrent: $7.87High

Loading 10-year price history...

BBOT Historical Performance

1 YearTotal Return
-30.4%
Price: -30.4%
3 YearsTotal Return
-25.8%
CAGR: -9.5%
Price: -25.8%
5 YearsTotal Return
-25.8%
CAGR: -5.8%
Price: -25.8%
YTD
-38.5%

BBOT Annual Returns

Year-by-year price performance · 2024–2026

Best+13.9%2025
Worst+3.0%2024
Up years2/3
2024+3.0%
2025+13.9%
2026-18.4%
2024 annual price return
+3.0%
2025 annual price return
+13.9%
2026 annual price return
-18.4%
LessMore
Alpha vs S&P 500
1Y-55.4%
3Y-28.5%
5Y-18.0%

Price returns only.

Download Historical Data

593 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

BBOT Stock Price Trajectory (2024–2026)

As of June 23, 2026, BridgeBio Oncology Therapeutics Inc. (BBOT) trades at $7.87, representing a -30.4% return over the past year. The stock has delivered a -25.8% total return over five years (-5.8% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $14.87 on December 8, 2025. From this peak, BBOT has corrected -47.1%, currently trading 25% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers BBIO (+65.7% 1Y), KYMR (+94.7% 1Y), and TPVG (-25.7% 1Y), BBOT has underperformed the peer group average. Compare BBOT vs BBIO →

BBOT Historical Price Data · from 2024

Rows 1–50 of 593
Date Open High Low Close Volume Change %
2026-06-227.738.047.667.87782K+4.10%
2026-06-187.727.827.527.561.33M-1.56%
2026-06-177.828.107.567.68555K-0.65%
2026-06-167.937.957.477.73384K0.00%
2026-06-157.807.807.557.73240K-0.26%
2026-06-127.467.827.447.75227K+3.89%
2026-06-117.127.557.017.46285K+4.78%
2026-06-107.237.597.077.12292K-1.93%
2026-06-098.008.107.237.26424K-6.68%
2026-06-088.108.107.707.78205K-0.38%
2026-06-058.138.137.637.81303K-5.10%
2026-06-048.118.338.048.2382K+2.49%
2026-06-038.208.267.888.03174K-2.90%
2026-06-028.608.758.218.27126K-3.27%
2026-06-018.958.958.518.55191K-4.68%
2026-05-298.799.258.578.97230K+1.47%
2026-05-288.508.938.418.84117K+3.63%
2026-05-278.378.758.338.53503K+1.91%
2026-05-268.558.717.968.37393K-2.11%
2026-05-229.029.258.408.550-6.15%
2026-05-218.719.268.659.11494K+3.41%
2026-05-208.759.088.658.81459K+1.03%
2026-05-198.658.858.418.72628K-0.34%
2026-05-188.468.788.168.75554K+2.82%
2026-05-158.378.558.068.51814K0.00%
2026-05-147.908.637.758.51341K+5.32%
2026-05-137.998.107.608.08274K-0.62%
2026-05-127.868.147.678.13219K+3.04%
2026-05-117.808.287.707.89302K+3.00%
2026-05-087.867.947.647.66234K-2.54%
2026-05-078.368.387.637.86373K-5.64%
2026-05-068.448.508.158.33152K+0.73%
2026-05-058.518.668.158.27158K-2.25%
2026-05-048.358.608.208.46235K+0.83%
2026-05-018.428.508.198.39155K-0.24%
2026-04-308.098.648.008.41328K+4.34%
2026-04-298.688.978.058.06564K-8.41%
2026-04-288.779.328.728.80461K+0.11%
2026-04-278.759.228.758.79523K+0.11%
2026-04-248.989.378.728.78385K-2.12%
2026-04-238.809.038.648.97381K+1.13%
2026-04-229.399.558.558.87796K-6.24%
2026-04-219.459.689.269.46904K+2.16%
2026-04-209.339.439.219.26552K-0.96%
2026-04-179.369.639.239.35586K+1.41%
2026-04-169.439.439.069.22244K-1.81%
2026-04-159.209.529.059.39522K+2.29%
2026-04-149.039.258.509.18577K+2.57%
2026-04-138.699.408.508.95931K+6.55%
2026-04-108.868.868.118.40290K-5.14%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

BBOT — Frequently Asked Questions

Quick answers to the most common questions about buying BBOT stock.

How has BBOT stock performed recently?

BBOT declined -30.4% over the past year, below its 5-year annualized CAGR of -5.8%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is BBOT's all-time high price?

BridgeBio Oncology Therapeutics Inc. reached $14.87 on 2025-12-08. The 52-week high is $14.87. Current 1-year return of -30.4% places the stock further from historical peaks.

Where can I download BBOT historical price data?

This page provides BBOT daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2024-2026, downloadable in CSV format.

297 data points · sampled from 593